Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Emergence of Monkeypox (MPX): A Close Relative of Small Pox During COVID-19 Era
Ivneet Kour1, Lipika Singhal1, Sonia Mehta2
1Department of Microbiology, Government Medical College & Hospital, Chandigarh, 160030, India.
Abstract:
After the eradication of smallpox (SPX), a new zoonotic threat that can trigger outbreaks has emerged. It may be fatal during the COVID19 outbreak. Humanity continues to be threatened due to re-emergence of the outbreaks. In most cases, new emerging viral agents originate from nonhuman hosts with zoonotic origins. Recent outbreaks of zoonotic infectious diseases with the potential to cause epidemics and pandemics continue to pose a major threat to the health security of entire regions, continents, and the world at large. Around five decades backthat Monkeypox (MPX) was reported for the first time in the Democratic Republic of the Congo (DRC) and was then confined to Central Africa only. Over the time, it has spread to other regions of Africa as well as outside Africa. As of August 2022, 40398 infections have been confirmed in almost 68 countries that have never reported MPX before. The majority of infections have been reported in Europe and Southeast Asia. On 23rd August 2022, MPX was declared a public health emergency of international concern, a step below declaring any disease as a pandemic. The article discusses the recent history of MPX outbreaks, as well as the evolving clinical manifestations of the disease, and the possible causes of the increase in cases, including the cessation of SPX vaccinations.
Insights
Monkeypox (MPX), a zoonotic disease, has re-emerged globally, posing a significant public health threat. Factors like the cessation of smallpox vaccinations may contribute to its spread and evolving clinical manifestations.
Area of Science:
- * Public Health
- * Infectious Diseases
- * Epidemiology
Background:
- * Emerging zoonotic diseases, like Monkeypox (MPX), pose significant global health security risks.
- * MPX, first identified in the Democratic Republic of the Congo, has spread beyond Central Africa.
- * The recent global outbreak has led to its declaration as a public health emergency of international concern.
Purpose of the Study:
- * To discuss the recent history and epidemiology of Monkeypox outbreaks.
- * To analyze the evolving clinical manifestations of the disease.
- * To explore potential causes for the increase in MPX cases, including the impact of smallpox vaccination cessation.
Main Methods:
- * Review of recent MPX outbreak data and historical records.
- * Analysis of epidemiological trends and geographical spread.
- * Examination of clinical case reports and potential contributing factors.
Main Results:
- * As of August 2022, over 40,000 MPX infections were confirmed in 68 countries, predominantly in Europe and Southeast Asia.
- * MPX has demonstrated an expanding geographical reach and evolving clinical presentations.
- * The cessation of smallpox (SPX) vaccinations is considered a potential factor in the increased susceptibility and spread.
Conclusions:
- * The re-emergence of Monkeypox represents a substantial global health challenge.
- * Understanding the changing epidemiology and clinical features is crucial for effective control.
- * Further research into the role of vaccination history and other contributing factors is warranted.
Related Concept Videos
Viral Recombination
Cross-reactivity
Viral Mutations
Causality in Epidemiology
Single Nucleotide Polymorphisms-SNPs
Principles of Disease Surveillance

